News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
143,945 Results
Type
Article (9002)
Company Profile (61)
Press Release (134882)
Section
Business (41951)
Career Advice (113)
Deals (6533)
Drug Delivery (12)
Drug Development (26750)
Employer Resources (15)
FDA (3850)
Job Trends (3900)
News (77307)
Policy (5800)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (484)
Adcomms (10)
Allergies (8)
Alliances (12437)
ALS (9)
Alzheimer's disease (200)
Antibody-drug conjugate (ADC) (90)
Approvals (3887)
Artificial intelligence (79)
Autoimmune disease (4)
Automation (1)
Bankruptcy (59)
Best Places to Work (3610)
BIOSECURE Act (1)
Biosimilars (32)
Biotechnology (53)
Bladder cancer (47)
Brain cancer (22)
Breast cancer (183)
Cancer (1416)
Cardiovascular disease (19)
Career advice (98)
Career pathing (3)
CAR-T (71)
Cell therapy (159)
Cervical cancer (10)
Clinical research (22110)
Collaboration (317)
Compensation (86)
Complete response letters (1)
COVID-19 (486)
CRISPR (10)
C-suite (73)
Cystic fibrosis (21)
Data (727)
Decentralized trials (1)
Depression (7)
Diabetes (24)
Diagnostics (1418)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (41)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (6)
Earnings (14360)
Editorial (8)
Employer branding (2)
Employer resources (15)
Events (25314)
Executive appointments (203)
FDA (4162)
Featured Employer (11)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (163)
Gene editing (19)
Generative AI (7)
Gene therapy (51)
GLP-1 (105)
Government (779)
Guidances (10)
Healthcare (4523)
Huntington's disease (2)
IgA nephropathy (5)
Immunology and inflammation (29)
Indications (13)
Infectious disease (509)
Inflammatory bowel disease (31)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (23)
Interviews (19)
IPO (3214)
IRA (7)
Job creations (522)
Job search strategy (85)
Kidney cancer (10)
Labor market (2)
Layoffs (122)
Leadership (2)
Legal (567)
Liver cancer (38)
Lung cancer (233)
Lymphoma (84)
Management (5)
Manufacturing (44)
MASH (6)
Medical device (1565)
Medtech (1565)
Mergers & acquisitions (3439)
Metabolic disorders (62)
Multiple sclerosis (17)
NASH (2)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (281)
NextGen: Class of 2025 (1096)
Non-profit (563)
Northern California (772)
Now hiring (6)
Obesity (31)
Opinion (35)
Ovarian cancer (54)
Pain (7)
Pancreatic cancer (49)
Parkinson's disease (19)
Partnered (2)
Patents (38)
Patient recruitment (32)
Peanut (5)
People (13689)
Pharmaceutical (14)
Pharmacy benefit managers (1)
Phase I (8178)
Phase II (9305)
Phase III (7171)
Pipeline (329)
Podcasts (11)
Policy (13)
Postmarket research (545)
Preclinical (2704)
Press Release (2)
Prostate cancer (64)
Psychedelics (3)
Radiopharmaceuticals (164)
Rare diseases (78)
Real estate (823)
Recruiting (6)
Regulatory (4960)
Reports (10)
Research institute (768)
Resumes & cover letters (12)
RNA editing (1)
RSV (9)
Schizophrenia (15)
Series A (35)
Series B (10)
Service/supplier (1)
Sickle cell disease (17)
Southern California (592)
Special edition (1)
Spinal muscular atrophy (16)
Sponsored (3)
Startups (824)
State (1)
Stomach cancer (9)
Supply chain (10)
The Weekly (11)
United States (5664)
Vaccines (147)
Venture capitalists (13)
Webinars (2)
Weight loss (17)
Women's health (1)
Date
Today (34)
Last 7 days (165)
Last 30 days (769)
Last 365 days (10040)
2025 (2050)
2024 (10432)
2023 (11749)
2022 (15261)
2021 (15317)
2020 (12946)
2019 (9830)
2018 (7329)
2017 (8179)
2016 (7350)
2015 (8058)
2014 (5367)
2013 (3826)
2012 (4053)
2011 (4193)
2010 (3645)
Location
Africa (100)
Alabama (21)
Alaska (2)
Arizona (17)
Arkansas (2)
Asia (11575)
Australia (1634)
California (1568)
Canada (434)
China (231)
Colorado (47)
Connecticut (72)
Delaware (90)
Europe (22261)
Florida (201)
Georgia (9)
Idaho (8)
Illinois (148)
India (7)
Indiana (51)
Japan (68)
Kansas (8)
Kentucky (10)
Maine (3)
Maryland (210)
Massachusetts (1323)
Michigan (18)
Minnesota (71)
Missouri (6)
Montana (5)
Nebraska (2)
Nevada (7)
New Hampshire (7)
New Jersey (451)
New Mexico (4)
New York (411)
North Carolina (208)
Northern California (772)
Ohio (42)
Oklahoma (1)
Oregon (5)
Pennsylvania (275)
Rhode Island (5)
South America (136)
South Carolina (2)
Southern California (592)
Tennessee (15)
Texas (256)
Utah (41)
Virginia (21)
Washington D.C. (5)
Washington State (160)
Wisconsin (14)
143,945 Results for "surface oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Coherus Completes Surface Oncology Acquisition
Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the closing of the previously announced acquisition of Surface Oncology, Inc.
September 8, 2023
·
7 min read
Business
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
Surface Oncology today reported financial results and corporate highlights for the second quarter 2023.
August 2, 2023
·
15 min read
Genetown
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
Surface Oncology, Inc. announced that both Institutional Shareholder Services and Glass, Lewis & Co. have recommended Surface stockholders vote “FOR” the adoption of Surface’s merger agreement with Coherus BioSciences, Inc.
August 31, 2023
·
16 min read
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Press Releases
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
March 7, 2025
·
9 min read
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix Acquisition Corp. II worth $450 million in proceeds.
February 28, 2025
·
2 min read
·
Annalee Armstrong
Business
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
Surface Oncology today reported financial results and corporate highlights for the first quarter 2023, as well as anticipated near-term milestones.
May 4, 2023
·
8 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
BioMidwest
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact ® System in Japan beginning November 30, 2023.
December 5, 2023
·
5 min read
Press Releases
Advarra Unveils Oncology Research Pulse
March 12, 2025
·
3 min read
1 of 14,395
Next
